News
They are a type of medical treatment. Scientists make monoclonal antibodies, or mAbs, in a lab. They work like the natural antibodies your body makes to fight illness. They go out into your body ...
Advisers to the US Food and Drug Administration voted Thursday to endorse a monoclonal antibody designed to protect infants and some young toddlers from RSV. Members of the agency’s ...
Tocilizumab, branded Actemra by pharmaceutical company Genentech, is a monoclonal antibody now approved for treating Covid-19 in hospitalized adult patients in moderate to severe conditions.
Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...
In a paper published more recently in the journal Cell Host & Microbe, Tan and his colleagues identified two more monoclonal antibodies that both attack the spike protein’s stem helix.
A new antibody drug by pharmaceutical company inflaRx received FDA emergency use authorization to treat critically ill Covid-19 patients. One of the greatest hurdles for monoclonal antibody ...
Testing for anti-PF4 antibodies and parallel testing for monoclonal paraproteinemia were performed; platelet-activating anti-PF4 antibodies were identified, and an IgG lambda M protein was ...
Celltrion developed and manufactured the world’s first monoclonal antibody biosimilar, followed by the first and only subcutaneous (SC) formulation infliximab, ‘Remsima ® SC’, which was ...
A new Alzheimer’s disease monoclonal antibody treatment that takes aim at a new target for the progressive disease has shown promising results, according to Boston researchers. The Mass General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results